Tiantan Biological / China Biologic (泰邦生物集团)

Taibang Biologic Group (formerly listed as China Biologic Products Holdings, Inc.) is a leading Chinese biopharmaceutical company specializing in the collection, manufacturing, and commercialization of human plasma-based biological products. Originally established as Taibang Biologic Group in Beijing in 2002, the company provides a comprehensive range of plasma-derived therapies serving hospitals and healthcare institutions across China. The company was taken private in a transaction led by Centurium Capital and has 1,000–5,000 employees.